Mouse models of diabetic neuropathy
ILAR Journal
|March 12, 2014
Summary
Diabetic peripheral neuropathy (DPN) mouse models are crucial for understanding diabetes complications. This review details T1DM and T2DM models, aiding research into DPN causes and treatments.
Area of Science:
- Neurology
- Endocrinology
- Diabetology
Background:
- Diabetic peripheral neuropathy (DPN) is a common diabetes complication causing nerve degeneration, pain, and sensory loss.
- Current treatments for DPN are limited, with tight glycemic control being the primary strategy for type 1 diabetes patients.
- Understanding DPN pathogenesis is crucial for developing effective therapeutic interventions.
Purpose of the Study:
- To review established and emerging mouse models for studying type 1 (T1DM) and type 2 (T2DM) diabetic peripheral neuropathy.
- To highlight the neurologic phenotypes associated with different T1DM and T2DM mouse models.
- To provide guidance on selecting appropriate models for DPN research and discuss future directions.
Main Methods:
- Review of existing literature on T1DM and T2DM mouse models used in DPN research.
- Analysis of the primary neurologic phenotypes reported for each model.
- Discussion of criteria for model selection and emerging model systems.
Main Results:
- Several T1DM and T2DM mouse models are widely utilized for DPN research, each exhibiting distinct neuropathic characteristics.
- The selection of appropriate models is critical for accurate investigation of DPN pathophysiology.
- Emerging mouse models show promise for advancing DPN research.
Conclusions:
- Clinically relevant T1DM and T2DM mouse models are essential resources for advancing DPN research.
- Comprehensive characterization and phenotyping of these models will facilitate the study of DPN pathogenesis.
- Improved understanding from these models is key to developing novel therapeutic strategies for DPN.
